Jonathan Williman

Jonathan Williman

Auto-generated profile, based on publicly available information

Jonathan Williman

Department of Population Health University of Otago Christchurch New Zealand

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2013 in The Lancet
Verified
Journal Article
Closed access
CBChristopher Bullen
Christopher Bullen
CHColin Howe
Colin Howe
MLMurray Laugesen
Murray Laugesen
HMHayden McRobbie
Hayden McRobbie
VPVarsha Parag
Varsha Parag
NWNatalie Walker
Natalie Walker

1 October 2015 in Journal of Affective Disorders
Verified
Journal Article
Closed access
JFJames A. Foulds
James A. Foulds
SASimon J. Adamson
Simon J. Adamson
JBJoseph M. Boden
Joseph M. Boden
JWJonathan A. Williman
Jonathan A. Williman
RMRoger T. Mulder
Roger T. Mulder

1 February 2016 in European Journal of Vascular and Endovascular Surgery
Verified
Journal Article
Closed access
MKManar Khashram
Manar Khashram
JWJ.A. Williman
J.A. Williman
PHP.N. Hider
P.N. Hider
GJG.T. Jones
G.T. Jones
JRJ.A. Roake
J.A. Roake

26 January 2015 in Anesthesiology Research and Practice
Verified
Journal Article
Open access
PDF file
TPTracey Pons
Tracey Pons
ESEdward A. Shipton
Edward A. Shipton
JWJonathan Williman
Jonathan Williman
RMRoger T. Mulder
Roger T. Mulder
Anaesthetists in the acute and chronic pain teams are often involved in treating Complex Regional Pain Syndromes. Current literature about the risk factors for the onset of Complex Regional Pain Syndrome Type 1 (CRPS 1) remains sparse. This syndrome has a low prevalence, a highly variable presentation, and no gold standard for diagnosis. In the research setting, the pathogenesis of the syndrome continues to be elusive. There is a growing body of literature that addresses efficacy of a wide range of interventions as well as the likely mechanisms that contribute to the onset of CRPS 1. The objective for this systematic search of the literature focuses on determining the potential risk factors for the onset of CRPS 1. Eligible articles were analysed, dated 1996 to April 2014, and potential risk factors for the onset of CRPS 1 were identified from 10 prospective and 6 retrospective studies. Potential risk factors for the onset of CRPS 1 were found to include being female, particularly postmenopausal female, ankle dislocation or intra-articular fracture, immobilisation, and a report of higher than usual levels of pain in the early phases of trauma. It is not possible to draw definite conclusions as this evidence is heterogeneous and of mixed quality, relevance, and weighting strength against bias and has not been confirmed across multiple trials or in homogenous studies.

2 April 2018 in Personality and Mental Health
Verified
Journal Article
Closed access
PDF file
NGNikki Guy
Nikki Guy
GNGiles Newton‐Howes
Giles Newton‐Howes
HFHannah Ford
Hannah Ford
JWJonathan Williman
Jonathan Williman
JFJames Foulds
James Foulds

30 April 2010 in Epidemiology and Infection
Verified
Journal Article
Closed access
PDF file
SAS. B. Adlam
S. B. Adlam
SPS. Perera
S. Perera
RLR. J. Lake
R. J. Lake
DCD. M. Campbell
D. M. Campbell
JWJ. A. Williman
J. A. Williman
MBM. G. Baker
M. G. Baker
SUMMARY: We report the results of the New Zealand Acute Gastrointestinal Illness (AGI) Community Study, a representative cross-sectional community telephone survey of 3655 participants conducted over a 12-month period. Respondents were asked questions about vomiting and diarrhoea in the previous 4 weeks. At least one episode of diarrhoea and/or vomiting was reported by 8·6% of respondents, an incidence of 1·11 episodes/person per year. Prevalence was highest in children aged 64 years. The mean duration of illness was 2·5 days and most common symptoms were diarrhoea (82·5%), stomach cramps (75·7%), nausea (56·9%) and vomiting (49·0%). Extrapolation of the adjusted estimates indicates there are about 4·66 million episodes of AGI per year in New Zealand, nearly 1 million visits to the general medical practitioner, in excess of 300 000 courses of antibiotics being dispensed and more than 4·5 million days of paid work lost due to AGI. This represents a significant burden of disease.